Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes

Department of Medicine, Umea University Hospital, Umea, Sweden.

OBJECTIVE: Glucocorticoid excess leads to insulin resistance. This study explores the effects of glucocorticoids on the glucose transport system and insulin signalling in rat adipocytes. The interaction between glucocorticoids and high levels of insulin and glucose is also addressed. DESIGN AND METHODS: Isolated rat adipocytes were cultured for 24 h at different glucose concentrations (5 and 15 mmol/l) with or without the glucocorticoid analogue dexamethasone (0.3 micromol/l) and insulin (10(4) microU/ml). After the culture period, the cells were washed and then basal and insulin-stimulated glucose uptake, insulin binding and lipolysis as well as cellular content of insulin signalling proteins (insulin receptor substrate-1 (IRS-1), IRS-2, phosphatidylinositol 3-kinase (PI3-K) and protein kinase B (PKB)) and glucose transporter isoform GLUT4 were measured. RESULTS: Dexamethasone in the medium markedly decreased both basal and insulin-stimulated glucose uptake at both 5 and 15 mmol/l glucose (by approximately 40-50%, P<0.001 and P<0.05 respectively). Combined long-term treatment with insulin and dexamethasone exerted additive effects in decreasing basal, and to a lesser extent insulin-stimulated, glucose uptake capacity (P<0.05) compared with dexamethasone alone, but this was seen only at high glucose (15 mmol/l). Insulin binding was decreased (by approximately 40%, P<0.05) in dexamethasone-treated cells independently of surrounding glucose concentration. Following dexamethasone treatment a approximately 75% decrease (P<0.001) in IRS-1 expression and an increase in IRS-2 (by approximately 150%, P<0.001) was shown. Dexamethasone also induced a subtle decrease in PI3-K (by approximately 20%, P<0.01) and a substantial decrease in PKB content (by approximately 45%, P<0.001). Insulin-stimulated PKB phosphorylation was decreased (by approximately 40%, P<0.01) in dexamethasone-treated cells. Dexamethasone did not alter the amount of total cellular membrane-associated GLUT4 protein. The effects of dexamethasone per se on glucose transport and insulin signalling proteins were mainly unaffected by the surrounding glucose and insulin levels. Dexamethasone increased the basal lipolytic rate (approximately 4-fold, P<0.05), but did not alter the antilipolytic effect of insulin. CONCLUSIONS: These results suggest that glucocorticoids, independently of the surrounding glucose and insulin concentration, impair glucose transport capacity in fat cells. This is not due to alterations in GLUT4 abundance. Instead dexamethasone-induced insulin resistance may be mediated via reduced cellular content of IRS-1 and PKB accompanied by a parallel reduction in insulin-stimulated activation of PKB.

This article has been cited by other articles:

				L. L. Gathercole, I. J. Bujalska, P. M. Stewart, and J. W. Tomlinson Glucocorticoid Modulation of Insulin Signaling in Human Subcutaneous Adipose Tissue J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4332 - 4339. [Abstract] [Full Text] [PDF]

				S. Bose, M A. Farah, H.-C. Jung, J.-H. Lee, and Y. Kim Molecular mechanism of bis(maltolato)oxovanadium(IV)-induced insulin signaling in 3T3-L1 and IM9 cells: impact of dexamethasone J. Mol. Endocrinol., June 1, 2007; 38(6): 627 - 649. [Abstract] [Full Text] [PDF]

				C. Le Foll, C. Corporeau, V. Le Guen, J.-P. Gouygou, J.-P. Berge, and J. Delarue Long-chain n-3 polyunsaturated fatty acids dissociate phosphorylation of Akt from phosphatidylinositol 3'-kinase activity in rats Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1223 - E1230. [Abstract] [Full Text] [PDF]

				S. Z. Yacoub Wasef, K. A. Robinson, M. N. Berkaw, and M. G. Buse Glucose, dexamethasone, and the unfolded protein response regulate TRB3 mRNA expression in 3T3-L1 adipocytes and L6 myotubes Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1274 - E1280. [Abstract] [Full Text] [PDF]

				S. B. Choi, J. S. Jang, S. M. Hong, D. W. Jun, and S. Park Exercise and dexamethasone oppositely modulate {beta}-cell function and survival via independent pathways in 90% pancreatectomized rats. J. Endocrinol., August 1, 2006; 190(2): 471 - 482. [Abstract] [Full Text] [PDF]

				M. Lowenberg, J. Tuynman, M. Scheffer, A. Verhaar, L. Vermeulen, S. van Deventer, D. Hommes, and M. Peppelenbosch Kinome Analysis Reveals Nongenomic Glucocorticoid Receptor-Dependent Inhibition of Insulin Signaling Endocrinology, July 1, 2006; 147(7): 3555 - 3562. [Abstract] [Full Text] [PDF]

				M. Lappas, K. Yee, M. Permezel, and G. E Rice Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies J. Endocrinol., September 1, 2005; 186(3): 457 - 465. [Abstract] [Full Text] [PDF]

				M. Sadagurski, G. Weingarten, C. J. Rhodes, M. F. White, and E. Wertheimer Insulin Receptor Substrate 2 Plays Diverse Cell-specific Roles in the Regulation of Glucose Transport J. Biol. Chem., April 15, 2005; 280(15): 14536 - 14544. [Abstract] [Full Text] [PDF]

				S. A. Summers and D. H. Nelson A Role for Sphingolipids in Producing the Common Features of Type 2 Diabetes, Metabolic Syndrome X, and Cushing's Syndrome Diabetes, March 1, 2005; 54(3): 591 - 602. [Abstract] [Full Text] [PDF]

				L.-L. Wang, C.-C. Ou, and J. Y.H. Chan Receptor-Independent Activation of GABAergic Neurotransmission and Receptor-Dependent Nontranscriptional Activation of Phosphatidylinositol 3-kinase/Protein Kinase Akt Pathway in Short-Term Cardiovascular Actions of Dexamethasone at the Nucleus Tractus Solitarii of the Rat Mol. Pharmacol., February 1, 2005; 67(2): 489 - 498. [Abstract] [Full Text] [PDF]

				D. Xu, A. Makkinje, and J. M. Kyriakis Gene 33 Is an Endogenous Inhibitor of Epidermal Growth Factor (EGF) Receptor Signaling and Mediates Dexamethasone-induced Suppression of EGF Function J. Biol. Chem., January 28, 2005; 280(4): 2924 - 2933. [Abstract] [Full Text] [PDF]

				M. Korach-Andre, J. Gao, J. S. Gounarides, R. Deacon, A. Islam, and D. Laurent Relationship between visceral adiposity and intramyocellular lipid content in two rat models of insulin resistance Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E106 - E116. [Abstract] [Full Text] [PDF]

				M. S. Rhee, A. Perianayagam, P. Chen, J. H. Youn, and A. A. McDonough Dexamethasone treatment causes resistance to insulin-stimulated cellular potassium uptake in the rat Am J Physiol Cell Physiol, November 1, 2004; 287(5): C1229 - C1237. [Abstract] [Full Text] [PDF]

				M. Lundgren, J. Buren, T. Ruge, T. Myrnas, and J. W. Eriksson Glucocorticoids Down-Regulate Glucose Uptake Capacity and Insulin-Signaling Proteins in Omental But Not Subcutaneous Human Adipocytes J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2989 - 2997. [Abstract] [Full Text] [PDF]

				K. Du, S. Herzig, R. N. Kulkarni, and M. Montminy TRB3: A tribbles Homolog That Inhibits Akt/PKB Activation by Insulin in Liver Science, June 6, 2003; 300(5625): 1574 - 1577. [Abstract] [Full Text] [PDF]

				N. G. Patel, J. C. Holder, S. A. Smith, S. Kumar, and M. C. Eggo Differential Regulation of Lipogenesis and Leptin Production by Independent Signaling Pathways and Rosiglitazone During Human Adipocyte Differentiation Diabetes, January 1, 2003; 52(1): 43 - 50. [Abstract] [Full Text] [PDF]